← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Shuttle Pharmaceuticals, Llc
Rockville, MD
$5,531,722
Total funding
5
Grants
Funding over time
peak $1.9M · FY2014–19$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$5,531,722 · 5
By mechanism
N43$2,144,277 · 3
N44$1,903,095 · 1
N01$1,484,350 · 1
Investigators at Shuttle Pharmaceuticals, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
TOPIC 345: PREDICTIVE BIOMARKERS OF PROSTATE CANCER PATIENT SENSITIVITY FOR RADIATION LATE EFFECTS$1,903,095
N44 · FY2019 · CA
IGF::OT::IGF Topic 352: Cell-Based Models for Prostate Cancer Health Disparity Research - Moonshot Project (Phase II)$1,484,350
N01 · FY2018 · CA
Clinical Development of IPdR for Radiosensitization$1,428,117
N44 · FY2015 · CA
IGF::OT::IGF PREDICTIVE BIOMARKERS OF PROSTATE CANCER PATIENT SENSITIVITY FOR RADIATION LATE EFFECTS$299,502
N43 · FY2016 · CA
IGF::OT::IGF SBIR PHASE I TOPIC 352 CELL-BASED MODELS FOR PROSTATE CANCER HEALTH DISPARITY RESEARCH$224,687
N43 · FY2016 · CA
Clinical Development of IPdR for Radiosensitization$191,971
N43 · FY2014 · CA